Lee S. Schwartzberg MD, FACP
Chief, Medical Oncology and Hematology, Renown Institute for Cancer, and Professor of Clinical Medicine, University of Nevada, Reno, NevadaDr. Lee Schwartzberg is Chief, Medical Oncology and Hematology at the Renown Institute for Cancer and Professor of Clinical Medicine at the University of Nevada, Reno. He completed his hematology/oncology fellowship at Memorial Sloan Kettering Cancer Center and spent 3 decades at West Cancer Center and Research Institute as Medical Director. He was Chief, Division of Hematology/Oncology and Professor of Medicine at the University of Tennessee Health Science Center from 2012 to 2017.
In 2018, he became the founding Chief Medical Officer of OneOncology, a national oncology practice management company and served in that role through 2021. He previously served on the Board of Directors and the Guideline Steering Committee of the National Comprehensive Cancer Network and participated in several guideline committees, including the committee for breast cancer.
Dr. Schwartzberg has published nearly 300 peer-reviewed manuscripts, book chapters, and monographs. He is the founding Editor-in-Chief of the Elsevier website PracticeUpdate Oncology and the founding Editor-in-Chief of the journal Community Oncology. His research interests focus on breast cancer, supportive care, precision medicine, and patient-reported outcomes. Dr. Schwartzberg maintains a clinical practice in breast cancer.
Disclosures
- Consultant: Amgen; Pfizer; Helsinn; Genentech; BMS (Bristol; Myer; Squibb); Myriad; AstraZeneca; Spectrum; Napo
- Advisory boards: Genomic Health Research Funding (Institution): Amgen; DSMB: Bayer
Recent Contributions to PracticeUpdate:
- Top 5 Studies in Breast Cancer From ASCO 2021
- Neoadjuvant Trastuzumab, Pertuzumab, and Docetaxel vs T-DM1 in ERBB2-Positive Breast Cancer
- Measuring Ovarian Escape in Premenopausal ER-Positive Breast Cancer Patients on Ovarian Suppression Therapy
- Adjuvant Olaparib for Patients With BRCA1- or BRCA2-Mutated Breast Cancer
- Communicating With Patients and Family Members
- Prevalence of Pathogenic Variants in Cancer Susceptibility Genes in Black Women and Non-Hispanic White Women With Breast Cancer
- ASCO 2021: Abstract Recommendations From Dr. Lee Schwartzberg for Breast Cancer
- Survival After Breast Conservation vs Mastectomy Adjusted for Comorbidity and Socioeconomic Status
- Grief Management for Healthcare Professionals
- Pertuzumab Plus High-Dose Trastuzumab for Progressive Brain Metastases and HER2+ Metastatic Breast Cancer